Clinical Trial

Outcome of Treatment With Botulinum toxinA in Patients With Temporomandibular Myofascial Pain

Completed Phase 4
View on ClinicalTrials.gov →
Summary
Purpose: The aim of this study is to investigate the effectiveness and patient reported outcomes (interincisal distance and temporomandibular myofascial pain) of treatment with intramuscularly administered BTX-A vs N/S in patients with temporomandibular myofascial pain. OBJECTIVES: To determine the outcome of treatment with botulinum toxin-A vs N/S in patients with temporomandibular myofascial pain.
Trial Details
NCT Number NCT07668375
Lead Sponsor PAEC General Hospital, Islamabad
Conditions Myofascial Pain - Dysfunction Syndrome of TMJ
Enrollment 118 participants
Start Date 2026-01-02
Primary Completion 2026-04-01 (estimated)
Study Completion 2026-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-25